Chemotherapy Generic Medicine Hospitals 
European Pharmaceutical Review
JANUARY 30, 2024
The CHMP recommended Exblifep (cefepime/enmetazobactam) as a treatment for complicated urinary tract infections, including pyelonephritis, hospital-acquired pneumonia, including ventilator associated pneumonia, and for treating bacteraemia caused by the aforementioned infections.
European Pharmaceutical Review
APRIL 30, 2024
If approved, fruquintinib could provide a new oral, chemotherapy-free option as the first and only selective inhibitor of all three vascular endothelial growth factor receptors (VEGFR) receptors approved in the EU for this disease, according to Takeda. This covers paediatric plaque psoriasis, psoriatic arthritis and Crohn’s disease.
Expert insights. Personalized for you.
98 
Let's personalize your content